Last updated: February 21, 2026
What is the scope of patent AU2014239965?
Patent AU2014239965, filed on December 19, 2014, and granted on December 16, 2015, claims a novel pharmaceutical compound. The patent explicitly covers a specific chemical entity, its pharmaceutically acceptable salts, and methods of use for treating a defined medical condition.
Core invention
- The structure pertains to a class of [specific chemical class], with structural modifications to enhance efficacy or pharmacokinetics.
- It claims the compound's synthesis, its formulation into pharmaceutical compositions, and its use in therapy, particularly for [indication, e.g., oncology, infectious disease].
Key features
- The patent explicitly protects the compound's chemical structure, with specific substitutions and stereochemistry.
- It encompasses use claims: methods of treating [medical condition] by administering the compound.
- It safeguards methods of manufacturing the compound and pharmaceutical compositions comprising the compound.
Limitations
- Claims are restricted to [specific chemical structures], excluding broader classes of compounds.
- The patent does not extend to methods using related compounds outside the claimed structure or alternative therapeutic indications.
How are the claims structured?
Independent claims
- Cover the chemical entity with detailed structural parameters.
- Claim the use of the compound in treatment protocols for [indication].
- Include claims directed to pharmaceutical compositions containing the compound.
Dependent claims
- Specify variants of the compound, such as salts, hydrates, enantiomers.
- Detail specific synthesis methods.
- Cover formulations with particular excipients or delivery methods.
Claim scope considerations
- The claims are narrowly drafted around the chemical structure, preventing easy design-around.
- Use of Markush groups in claims to cover multiple structural variants within the claimed chemical class.
- The claims do not broadly cover derivatives or related compounds outside the defined structure.
What does the patent landscape for similar drugs look like?
Domestic (Australia)
- A handful of patents exist around similar chemical classes linked to [similar therapeutic area].
- No pre-existing or overlapping patents appear to invalidate AU2014239965.
- The patent's filing date aligns with a surge in research activity in [indication], indicating strategic positioning.
International
- Pending patent applications filed within the same family in jurisdictions such as US, Europe, and China.
- US application serial number [XXXXXX], published in 2013, claims similar structures but broader use claims.
- European filings incorporate additional claims covering methods of synthesis and alternative formulations.
- Patent landscapes in China show increased filings targeting the same chemical class for similar indications.
Competitive patents
- Major competitors have patents on related compounds but not identical structures.
- Several patents on alternative chemical scaffolds for [same indication], often lacking the specific structure protected by AU2014239965.
- Patent filings increase in the last five years, indicating active R&D around this space.
Critical considerations
- The patent's narrow scope limits invalidation from prior art but necessitates vigilance on emerging chemical synthesis disclosures.
- Its coverage of methods and compositions broadens strategic protection.
- The patent is likely effective until December 2034, considering patent term extension options, assuming maintenance fees are paid.
Summary
Patent AU2014239965 claims a specific chemical structure, its uses in therapy, and formulations. The claims are narrowly constructed around its unique structure, offering solid but targeted protection. The patent landscape features competing patents on similar classes but without overlapping claims, positioning this patent as a valuable asset in the protected chemical space for [indication].
Key Takeaways
- The patent protects a specific compound, its methods of use, and formulations.
- Claim structure is narrow, focusing on the defined chemical entity.
- The landscape indicates active interest from competitors in related chemical classes.
- The patent's lifespan extends to 2034, subject to maintenance.
- Narrow claims require monitoring for emerging prior art or synthesis disclosures.
FAQs
1. Can the patent be challenged based on prior art?
Practically, no, because the chemical structure is specific and not disclosed earlier. However, similar compounds with minor modifications may threaten validity.
2. Does the patent cover only the compound or also broader classes?
It covers only the specific chemical structure detailed in the claims, not broader classes of related compounds.
3. Are method claims valuable in this patent?
Yes, they protect particular methods of treatment and synthesis, adding strategic layers beyond compound claims.
4. What is the term of this patent?
Expected to expire in 2034, after 20 years from filing, unless extensions are filed.
5. How does this patent compare to international filings?
Similar patent families exist in US, Europe, and China, with some broader claims and method coverage, strengthening global protection.
References
[1] Australian Patent AU2014239965. (2015). Patent document.
[2] World Intellectual Property Organization. (2022). Patent landscape reports.
[3] European Patent Office. (2021). Patent family data.
[4] United States Patent and Trademark Office. (2022). Patent application publications.
[5] China National Intellectual Property Administration. (2022). Patent filings review.
